Critical and honest conversations: The evidence behind the "choosing Wisely" campaign recommendations by the American society of nephrology

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 10, 2012, Pages 1664-1672

  Williams, Amy W ^a   Dwyer, Amy C ^b   Eddy, Allison A ^b   Fink, Jeffrey C ^b   Jaber, Bertrand L ^b   Linas, Stuart L ^b   Michael, Beckie ^b   O'Hare, Ann M ^b   Schaefer, Heidi M ^b   Shaffer, Rachel N ^b   Trachtman, Howard ^b   Weiner, Daniel E ^b   Falk, Ronald J ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIANEMIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; HEMOGLOBIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; RENIN INHIBITOR;

ANEMIA; ARTERIOVENOUS FISTULA; ARTICLE; CANCER SCREENING; CATHETERIZATION; CHRONIC KIDNEY DISEASE; DECISION MAKING; DIALYSIS; DRUG MARKETING; FAMILY; GOUT; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH PROMOTION; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FAILURE; LIFE EXPECTANCY; LOW DRUG DOSE; MEDICAL INFORMATION; MUSCULOSKELETAL PAIN; NEPHROLOGY; PAIN; PATIENT CARE; PATIENT SAFETY; PHYSICIAN;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATHETERIZATION, CENTRAL VENOUS; COST SAVINGS; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HEALTH CARE COSTS; HEALTH PROMOTION; HEALTH SERVICES MISUSE; HEMATINICS; HUMANS; MASS SCREENING; NEPHROLOGY; PATIENT SAFETY; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES AS TOPIC; PROFESSIONAL-FAMILY RELATIONS; PROGRAM DEVELOPMENT; QUALITY INDICATORS, HEALTH CARE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84867242739     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04970512     Document Type: Article

References (88)

1. ABIM Foundation: Choosing Wisely. Available at: http://choosingwisely.org/. Accessed May 12, 2012
2. American Society of Nephrology: Methodology Used to Create ASN's List. Available at: http://www.asn-online.org/policy_and_public_affairs/choosingwisely/ChoosingWiselyMethodology.pdf. Accessed May 12, 2012
3. Terret C, Castel-Kremer E, Albrand G, Droz JP: Effects of comorbidity on screening and early diagnosis of cancer in elderly people. Lancet Oncol 10: 80-87, 2009
4. United States Renal Data System: USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the Unites States. National Institute of Diabetes and Digestive and Kidney Diseases. Available at: http://www.usrds.org/adr.aspx. Accessed May 12, 2012
5. Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, McCredie M, Boyle P: Cancer in patients on dialysis for end-stage renal disease: An international collaborative study. Lancet 354: 93-99, 1999
6. Chertow GM, Paltiel AD, Owen WF Jr, Lazarus JM: Costeffectiveness of cancer screening in end-stage renal disease. Arch Intern Med 156: 1345-1350, 1996
7. LeBrun CJ, Diehl LF, Abbott KC, Welch PG, Yuan CM: Life expectancy benefits of cancer screening in the end-stage renal disease population. Am J Kidney Dis 35: 237-243, 2000
8. Kajbaf S, Nichol G, Zimmerman D: Cancer screening and life expectancy of Canadian patients with kidney failure. Nephrol Dial Transplant 17: 1786-1789, 2002
9. de Koning HJ, van Ineveld BM, van Oortmarssen GJ, de Haes JC, Collette HJ, Hendriks JH, van der Maas PJ: Breast cancer screening and cost-effectiveness: Policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 49: 531-537, 1991
10. Wong G, Howard K, Chapman JR, Craig JC: Cost-effectiveness of breast cancer screening in women on dialysis. Am J Kidney Dis 52: 916-929, 2008
11. Irwig L, McCaffery K, Salkeld G, Bossuyt P: Informed choice for screening: Implications for evaluation. BMJ 332: 1148-1150, 2006
12. Castellanos M, Varma S, Ahern K, Grosso SJ, Buchbinder S, D'Angelo D, Raia C, Kleiner M, Elsayegh S: Increased breast calcifications in women with ESRD on dialysis: Implications for breast cancer screening. Am J Kidney Dis 48: 301-306, 2006
13. Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, Roth D, Scandling JD, Singer GG; American Society of Transplantation: Recommendations for the outpatient surveillance of renal transplant recipients. J Am Soc Nephrol 11[Suppl 15]: S1-S86, 2000
14. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Longterm management of the transplant recipient. IV.1. Organization of follow-up of transplant patients after the first year. Nephrol Dial Transplant17 Suppl 4:3-4, 2002.
15. Wong G, Howard K, Tong A, Craig JC: Cancer screening in people who have chronic disease: The example of kidney disease. Semin Dial 24: 72-78, 2011
16. Canadian Erythropoietin Study Group: Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ 300: 573-578, 1990
17. The US Recombinant Human Erythropoietin Predialysis Study Group: Double-blind, placebo-controlled study of the therapeutic use of recombinant human erythropoietin for anemia associated with chronic renal failure in predialysis patients. Am J Kidney Dis 18: 50-59, 1991
18. Weiner DE, Miskulin DC: Anemia management in chronic kidney disease: Bursting the hemoglobin bubble. Ann Intern Med 153: 53-55, 2010
19. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339: 584-590, 1998
20. Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A; CREATE Investigators: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071-2084, 2006
21. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R; TREAT Investigators: A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361: 2019-2032, 2009
22. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D; CHOIR Investigators: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085-2098, 2006
23. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Ravani P, Jardine M, Perkovic V, Graziano G, McGee R, Nicolucci A, Tognoni G, Strippoli GF: Metaanalysis: Erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med 153: 23-33, 2010
24. KDOQI. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 50(3): 471-530, 2007
25. American College of Rheumatology. Information for patients about NSAIDs. June 2007. Available at: http://www.rheumatology.org/practice/clinical/patients/medications/nsaids.pdf. Accessed May 8, 2012
26. Pugner KM, Scott DI, Holmes JW, Hieke K: The costs of rheumatoid arthritis: an international long-term view. Semin Arthritis Rheum 29: 305-320, 2000
27. Antman EM, Bennett JS, Daugherty A, Furberg C, Roberts H, Taubert KA; American Heart Association: Use of nonsteroidal anti-inflammatory drugs: an update for clinicians: A scientific statement from the American Heart Association. Circulation 115: 1634-1642, 2007
28. Wolfe MM, Lichtenstein DR, Singh G: Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 340: 1888-1899, 1999
29. Plantinga L, Grubbs V, Sarkar U, Hsu CY, Hedgeman E, Robinson B, Saran R, Geiss L, Burrows NR, Eberhardt M, Powe N; CDC CKD Surveillance Team: Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States. Ann Fam Med 9: 423-430, 2011
30. Pugliese F, Cinotti GA: Nonsteroidal anti-inflammatory drugs (NSAIDs) and the kidney. Nephrol Dial Transplant 12: 386-388, 1997
31. Bouvy ML, Heerdink ER, Hoes AW, Leufkens HG: Effects of NSAIDs on the incidence of hospitalisations for renal dysfunction in users of ACE inhibitors. Drug Saf 26: 983-989, 2003
32. The Renal Association. Chronic kidney disease in adults: UK guidelines for identification, management and referral. 2006. Available at: http://www.renal.org/ckdguide/full/ukckdfull.pdf.Accessed August 25, 2012
33. Gooch K, Culleton BF, Manns BJ, Zhang J, Alfonso H, Tonelli M, Frank C, Klarenbach S, Hemmelgarn BR: NSAID use and progression of chronic kidney disease. Am J Med 120:280 e281-e287, 2007
34. National Heart, Lung, and Blood Institute, U.S. Department of Health and Human Services. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7). 2007. Available at: http://www.nhlbi.nih.gov/guidelines/hypertension/. Accessed May 8, 2012
35. National Kidney Foundation: KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39(2 Suppl 1):S1-S266, 2002
36. Scottish Intercollegiate Guidelines Network (SIGN): Management of chronic heart failure: A national clinical guideline. 2007. Available at:http://www.sign.ac.uk/pdf/sign95.pdf. Accessed May 8, 2012
37. Kasiske BL, Zeier MG, Chapman JR, Craig JC, Ekberg H, Garvey CA, Green MD, Jha V, Josephson MA, Kiberd BA, Kreis HA, McDonald RA, Newmann JM, Obrador GT, Vincenti FG, Cheung M, Earley A, Raman G, Abariga S, Wagner M, Balk EM; Kidney Disease: Improving Global Outcomes: KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary. Kidney Int 77: 299-311, 2010
38. Forman JP, Rimm EB, Curhan GC: Frequency of analgesic use and risk of hypertension among men. Arch Intern Med 167: 394-399, 2007
39. Fournier JP, Sommet A, Bourrel R, Oustric S, Pathak A, Lapeyre-Mestre M, Montastruc JL: Non-steroidal anti-inflammatory drugs (NSAIDs) and hypertension treatment intensification: A population-based cohort study[published online ahead of print April 15, 2012]. Eur J Clin Pharmacol doi: 10.1007/s00228-012-1283-9
40. Feenstra J, Heerdink ER, Grobbee DE, Stricker BH: Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: The Rotterdam Study. Arch Intern Med 162: 265-270, 2002
41. Hoggard J, Saad T, Schon D, Vesely TM, Royer T; American Society of Diagnostic and Interventional Nephrology, Clinical Practice Committee; Association for Vascular Access: Guidelines for venous access in patients with chronic kidney disease. A Position Statement from the American Society of Diagnostic and Interventional Nephrology, Clinical Practice Committee and the Association for Vascular Access. Semin Dial 21: 186-191, 2008
42. Allon M: Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis 44: 779-791, 2004
43. Lee T, Barker J, Allon M: Tunneled catheters in hemodialysis patients: Reasons and subsequent outcomes. AmJ KidneyDis 46: 501-508, 2005
44. Nori US, Manoharan A, Yee J, Besarab A: Comparison of lowdose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 48: 596-605, 2006
45. Rayner HC, Besarab A, Brown WW, Disney A, Saito A, Pisoni RL: Vascular access results from the Dialysis Outcomes and Practice Patterns Study (DOPPS): Performance against Kidney Disease Outcomes Quality Initiative (K/DOQI) Clinical Practice Guidelines. Am J Kidney Dis 44[Suppl 2]: 22-26, 2004
46. Allen AW, Megargell JL, Brown DB, Lynch FC, Singh H, Singh Y, Waybill PN: Venous thrombosis associatedwith the placement of peripherally inserted central catheters. J Vasc Interv Radiol 11: 1309-1314, 2000
47. Gonsalves CF, Eschelman DJ, Sullivan KL, DuBois N, Bonn J: Incidence of central vein stenosis and occlusion following upper extremity PICC and port placement. Cardiovasc Intervent Radiol 26: 123-127, 2003
48. Barrett N, Spencer S, McIvor J, Brown EA: Subclavian stenosis: A major complication of subclavian dialysis catheters. Nephrol Dial Transplant 3: 423-425, 1988
49. Schwab SJ, Quarles LD, Middleton JP, Cohan RH, Saeed M, Dennis VW: Hemodialysis-associated subclavian vein stenosis. Kidney Int 33: 1156-1159, 1988
50. Spinowitz BS, Galler M, Golden RA, Rascoff JH, Schechter L, Held B, Charytan C: Subclavian vein stenosis as a complication of subclavian catheterization for hemodialysis. Arch Intern Med 147: 305-307, 1987
51. El Ters M, Schears GJ, Taler SJ, Williams AW, Albright RC, Jenson BM, Mahon AL, Stockland AH, Misra S, Nyberg SL, Rule AD, Hogan MC: Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: A casecontrol study in hemodialysis patients [Epub ahead of print June 14, 2012]. Am J Kidney Dis doi:10.1053/j.ajkd.2012.05.007
52. Mau LW, Liu J, Qiu Y, Guo H, Ishani A, Arneson TJ, Gilbertson DT, Dunning SC, Collins AJ: Trends in patient characteristics and firstyearmedical costs of older incident hemodialysis patients, 1995-2005. Am J Kidney Dis 55: 549-557, 2010
53. Knauf F, Aronson PS: ESRDas awindow into America's cost crisis in health care. J Am Soc Nephrol 20: 2093-2097, 2009
54. O'Hare AM, Rodriguez RA, Hailpern SM, Larson EB, Kurella Tamura M: Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults. JAMA 304: 180-186, 2010
55. Hallan SI, Coresh J, Astor BC, Asberg A, Powe NR, Romundstad S, Hallan HA, Lydersen S, Holmen J: International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 17: 2275-2284, 2006
56. Kaufman SR, Shim JK, Russ AJ: Old age, life extension, and the character of medical choice. J Gerontol B Psychol Sci Soc Sci 61: S175-S184, 2006
57. Davison SN, Jhangri GS, Holley JL, Moss AH: Nephrologists' reported preparedness for end-of-life decision-making. Clin J Am Soc Nephrol 1: 1256-1262, 2006
58. Davison SN: End-of-life care preferences and needs: Perceptions of patientswith chronic kidney disease. Clin J AmSocNephrol 5: 195-204, 2010
59. Murtagh F, Cohen LM, Germain MJ: Dialysis discontinuation: Quo vadis? Adv Chronic Kidney Dis 14: 379-401, 2007
60. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L: United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis 53[Suppl]: S1-S374, 2009
61. Schell JO, Patel UD, Steinhauser KE, Ammarell N, Tulsky JA: Discussions of the kidney disease trajectory by elderly patients and nephrologists: Aqualitative study. Am J Kidney Dis 59: 495-503, 2012
62. O'Hare AM, Batten A, Burrows NR, Pavkov ME, Taylor L, Gupta I, Todd-Stenberg J, Maynard C, Rodriguez RA, Murtagh FE, Larson EB, Williams DE: Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis 59: 513-522, 2012
63. Rosansky SJ, Clark WF, Eggers P, Glassock RJ: Initiation of dialysis at higher GFRs: Is the apparent rising tide of early dialysis harmful or helpful? Kidney Int 76: 257-261, 2009
64. O'Hare AM, Choi AI, Boscardin WJ, Clinton WL, Zawadzki I, Hebert PL, Kurella Tamura M, Taylor L, Larson EB: Trends in timing of initiation of chronic dialysis in the United States. Arch Intern Med 171: 1663-1669, 2011
65. Kurella M, Covinsky KE, Collins AJ, Chertow GM: Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 146: 177-183, 2007
66. Jassal SV, Trpeski L, Zhu N, Fenton S, Hemmelgarn B: Changes in survival among elderly patients initiating dialysis from 1990 to 1999. CMAJ 177: 1033-1038, 2007
67. Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE: Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361: 1539-1547, 2009
68. Jassal SV, Chiu E, Hladunewich M: Loss of independence in patients starting dialysis at 80 years of age or older. N Engl J Med 361: 1612-1613, 2009
69. Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA; IDEAL Study: A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363: 609-619, 2010
70. Harris A, Cooper BA, Li JJ, Bulfone L, Branley P, Collins JF, Craig JC, Fraenkel MB, Johnson DW, Kesselhut J, Luxton G, Pilmore A, Rosevear M, Tiller DJ, Pollock CA, Harris DC: Cost-effectiveness of initiating dialysis early: A randomized controlled trial. Am J Kidney Dis 57: 707-715, 2011
71. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE: Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 22: 1955-1962, 2007
72. Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K: Survival of elderly patients with stage 5 CKD: Comparison of conservativemanagement and renal replacement therapy. Nephrol Dial Transplant 26: 1608-1614, 2011
73. Carson RC, Juszczak M, Davenport A, Burns A: Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol 4: 1611-1619, 2009
74. Rheault MN, Rajpal J, Chavers B, Nevins TE: Outcomes of infants,28 days old treated with peritoneal dialysis for end-stage renal disease. Pediatr Nephrol 24: 2035-2039, 2009
75. Rees L: Management of the neonate with chronic renal failure. Semin Fetal Neonatal Med 13: 181-188, 2008
76. Shroff R, Rees L, Trompeter R, Hutchinson C, Ledermann S: Longterm outcome of chronic dialysis in children. Pediatr Nephrol 21: 257-264, 2006
77. Mehler K, Beck BB, Kaul I, Rahimi G, Hoppe B, Kribs A: Respiratory and general outcome in neonates with renal oligohydramnios-a single-centre experience. Nephrol Dial Transplant 26: 3514-3522, 2011
78. Barry MJ, Edgman-Levitan S: Shared decision making-pinnacle of patient-centered care. N Engl J Med 366: 780-781, 2012
79. Germain MJ, Davison SN, Moss AH: When enough is enough: The nephrologist's responsibility in ordering dialysis treatments. Am J Kidney Dis 58: 135-143, 2011
80. Kirchhoff KT, Hammes BJ, Kehl KA, Briggs LA, Brown RL: Effect of a disease-specific advance care planning intervention on endof-life care. J Am Geriatr Soc 60: 946-950, 2012
81. American Society of Nephrology and Renal Physicians Association: Shared decision-making in the appropriate initiation of and withdrawal from dialysis, Washington, DC, Renal Physicians Association,2000
82. Renal Physicians Association: Shared decision-making in the appropriate initiation of and withdrawal from dialysis, 2nd Ed., Rockville, MD, 2010
83. Weir MR: Microalbuminuria and cardiovascular disease. Clin J Am Soc Nephrol 2: 581-590, 2007
84. Artunc F, Risler T: Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease. Nephrol Dial Transplant 22: 2900-2908, 2007
85. Fehr T, Ammann P, Garzoni D, Korte W, Fierz W, Rickli H, Wüthrich RP: Interpretation of erythropoietin levels in patients with various degrees of renal insufficiency and anemia. Kidney Int 66: 1206-1211, 2004
86. Kato A, Hishida A, Kumagai H, Furuya R, Nakajima T, Honda N: Erythropoietin production in patients with chronic renal failure. Ren Fail 16: 645-651, 1994
87. Ross RP, McCrea JB, Besarab A: Erythropoietin response to blood loss in hemodialysis patients in blunted but preserved. ASAIO J 40: M880-M885, 1994
88. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease: Am J Kidney Dis 47: S11-S145, 2006